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INTRODUCTION
We have previously isolated a novel trypsin- like protease from
human mucoid sputum and named it as human airway trypsin- like
protease (HAT) (1). Analysis of the nucleotide sequence of cloned
HAT cDNA suggested that HAT is originally translated as a pre-
cursor with a molecular size of 47 kDa (composed of 418 amino
acid residues), whose N-terminal proximal region contains a hy-
drophobic putative transmembrane domain (2). Since the discov-
ery of HAT, several serine proteases with properties similar to
those of HAT have also been discovered, and recently, HAT has
been classified as a member of the typetransmembrane serine
proteases, and named TMPRSS11D (3, 4).
Precursor HAT is converted to an active enzyme by limited
proteolysis between the Arg186

Ile187 peptide bond and is proc-
essed into the soluble form, mature HAT, containing 232 amino
acid residues (187

418) in the extracellular space (2). This mature
HAT may be involved in some important physiological processes.
Previous investigators have showed by immunohistochemistry
that HAT protein is strongly expressed in the lower respiratory
tract, e.g., bronchial epithelium (5-7), and in oral tissues, such as
tonsils and buccal epithelium (7). Analysis of HAT mRNA expres-
sion in various human tissues showed that significant expression is
observed in the trachea and in the upper gastrointestinal tract (par-
ticularly in the esophagus and tongue) as well as in other organs
such as the bladder, testis, and spinal cord (4, 8, 9). These studies
strongly indicated that HAT is distributed in various tissues, par-
ticularly in the lower and upper respiratory and upper gastrointesti-
nal tracts, including oral tissues.
Mature HAT was first discovered in the sputum (1, 10-12). Hy-
pertonic saline- induced sputum sample (12) and bronchial wash-
ings from healthy volunteers also contained mature HAT (unpub-
lished data). These results indicated that the lower respiratory
fluid, so-called bronchial secretions or sputum, contains mature
HAT in both healthy and pathologic states. However, it is still un-
known whether mature HAT is present in human biological fluids
apart from airway secretions.
As described above, expression of HAT mRNA in oral tissues has
been previously reported (8-9). In a preliminary study, we have
shown by ELISA that human saliva contains HAT (13), and Sun
et al. reported the presence of HAT by activity -based mass spectro-
photometric characterization (14). However, till date no investiga-
tors have isolated mature HAT from saliva.
Saliva is involved in the defense mechanism of the oral mucous
membrane via various processes (15). We hypothesized that ma-
ture HAT may be released into the saliva and may be related to
some biological functions of the oral mucous membrane.
In the present study, we aimed to isolate mature HAT from saliva
and demonstrated that the saliva of healthy subjects contained
mature HAT at concentration similar to that in the sputum, and it
was shown by RT-PCR analysis that HAT was released from oral
epithelial cells. Moreover, recombinant HAT (rHAT) enhanced α -
smooth muscle actin fiber (α -SMA ; a marker for myofibroblast)
expression in gingival fibroblasts, indicating that HAT may pro-
mote fibroblast - to-myofibroblast differentiation in the oral cavity.
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MATERIALS AND METHODS
Reagents and Antibodies
rHAT, which corresponds to mature HAT (2), and two different
rabbit polyclonal IgG antibodies against rHAT were supplied by
Teijin Institute for Bio-Medical Research, Tokyo, Japan. The bio-
chemical properties of rHAT were almost similar to those of mature,
native HAT purified from the mucoid sputum (2).
Recombinant human TGF-β1 was obtained from R&D Systems
(Minneapolis, MN).
Streptavidin

horse radish peroxidase conjugate was purchased
from Biosource (Camarillo, CA). Dulbecco’s modified Eagle’s
medium (DMEM) and fetal bovine serum (FBS) were obtained
from Nacalai Tesque, Inc (Kyoto, Japan) and Invitrogen Corp
(Carlsbad, CA, USA), respectively. Keratinocyte-serum free me-
dium (SFM) supplemented with bovine pituitary extract (BPE) and
epidermal growth factor (EGF) was obtained from Invitrogen.
Bovine serum albumin (BSA) and Micro BCA protein assay re-
agent kit were obtained from Sigma (St Louis, MO, USA) and
Pierce (Rockford, IL, USA), respectively. Boc-Phe-Ser-Arg-4-
methyl -coumaryl -7 -amide (MCA) and other MCA substrates were
obtained from the Peptide Institute (Osaka, Japan). Triton X-100
and sodium dodecyl sulfate (SDS) were obtained from Sigma-
Aldrich (Tokyo, Japan). SephadexTM G-100 and Benzamidine-
SepharoseTM-6B were obtained from Pharmacia Fine Chemicals
(Uppsala, Sweden).Butyl - Toyopearl 650C and SP-Toyopearl 650
M were obtained from TOSOH (Tokyo, Japan).
Collection of whole saliva
The protocol was conducted in compliance with the guidelines of
Declaration of Helsinki. Saliva samples were obtained from 40 non-
smoker female volunteers aged 20

22-years-old and 62 non-
smoker female volunteers aged 35

55-years-old. Before collect-
ing the saliva, written informed consent was obtained from all sub-
jects after a full explanation of the procedures involved. The experi-
mental procedure was approved by the Ethics Committee of the
Tokushima University Hospital (Approval No 286, 117).
Saliva, unless otherwise stated, was collected by suction using a
low-pressure continuous aspirator (Sea Star Corporation, Kyoto)
via a bronchial catheter (Type P, 10Fr, Thermo fisher scientific,
CA), the tip of which was inserted into the floor of the mouth, by
gentle continuous suction for 5

30 min.
Saliva was collected from some subjects by the spitting method
according to the method of Nagler and Hershkovich (16). Saliva
samples were stored in a deep freezer at

80 until use.
Assay of protease activity
Trypsin- like activity was measured according to the method of
Yasuoka et al. (1). Briefly, the assay mixture (1.5 ml), containing 50
mM Tris-HCl (pH 8.6), 100 μMBoc-Phe-Ser-Arg-MCA, 100 μg/
ml BSA, and 100 μl of the test sample, was incubated at 37 for 60
min, and the reaction was stopped by adding 1 ml of 30% acetic acid.
The fluorescence intensity of the released aminomethyl coumarin
(AMC) was measured using a fluorescence spectrophotometer (F-
3010 Hitachi Co, Japan) at 440 nm with excitation at 380 nm. The
amount of AMC released was calculated from a standard curve.
One unit of enzyme was defined as the amount that produced 1
μmole of AMC per min.
Thirty nanomolar HAT exhibited an activity of 100 mU/ml.
ELISA for determining HAT concentration
In brief, 96-well plates (Micron, Greiner Labortechnik) were
coated with 50 μl of the primary antibody, a rabbit polyclonal anti -
rHAT antibody (10 μg/ml) in PBS, at 4 overnight. The plates
were blocked with 1% BSA in PBS at room temperature for 3 h.
Plates containing 50 μl each of the test sample or rHAT solution and
secondary biotinylated rabbit polyclonal anti -rHAT antibody solu-
tion (10 μg/ml) per well were incubated at 4 overnight. Then, the
plate containing 100 μl of a 6 × 105 - fold diluted streptavidin

horse
radish peroxidase conjugate solution per well was incubated at
room temperature for 1 h. Finally, the plate containing 100 μl of
0.023% tetramethylbenzidine dihydrochloride dihydrate (TMBZ·
HCl)/2.5 mM H2O2 was incubated at room temperature for 30 min.
The reaction was terminated using 100 μl of 1 N H2SO4 per well, and
absorption at 450 nm was measured using a microplate reader
(Model 550, Bio-Rad). The concentration range of HAT as meas-
ured by ELISA was 0.03

10 ng/ml.
Purification of trypsin-like protease obtained from saliva
When the activities of HAT purified from the sputum with
various MCA-substrates were previously tested, Boc-Phe-Ser-
Arg-MCA (a trypsin substrate) was the most preferentially hydro-
lyzed substrate by HAT (1). Therefore, a Boc-Phe-Ser-Arg-MCA-
hydrolyzing protease was purified from the pooled saliva by a minor
modification in the method previously adopted for purification of
HAT from the mucoid sputum (1). Briefly, equal volumes (approxi-
mately 650 ml) of pooled saliva and 0.10 M Tris-HCl (pH 7.5)/
0.30 M NaCl, were mixed and homogenized using a Polytron ho-
mogenizer and centrifuged. The supernatant was subjected to
hydrophobic gel column chromatography using Butyl -Toyopearl
650C column (column size, 4 × 12 cm) as described previously (1).
The active fraction eluted from the gel was precipitated with 65%
ammonium sulfate, dissolved in 30 ml of 0.05 M sodium acetate (pH
4.0)/10% glycerol, dialyzed in 3 l of the same buffer, and then
centrifuged. The supernatant was successively subjected to purifica-
tion procedures using a cation exchange gel column (SP-Toyopearl
650M) by both the bathwise method and column chromatography
(column size, 1.2 × 18 cm). The active fraction eluted with a
linear 0

0.2 M NaCl gradient from theSP-Toyopearl 650M column
was finally subjected to affinity column chromatography using
Benzamidine-Sepharose 6B column equilibrated with 0.05 Tris-
HCl buffer (pH 9.2)/0.5 M NaCl/10% glycerol (column size, 2 × 5
cm). After the column was washed with the equilibration buffer,
most of the trypsin- like protease was eluted with 0.05 M acetate
buffer (pH 4.0)/0.5 M NaCl/10% glycerol. The purification proce-
dure was performed four times. Each active fraction from Benza-
midine-Sepharose 6B column chromatography was combined,
concentrated by ultrafiltration, and dissolved in 5 ml of 0.05 M Tris-
HCL buffer (pH 7.5)/0.1 M NaCl. Approximately 2 μg of the puri-
fied enzyme (8% yield) was obtained after purification, with activity
about 330,000- fold that of the starting material.
Analyses of trypsin-like activity and HAT concentration in whole
saliva
For determining trypsin- like activity and HAT concentration in
the saliva samples, collection of whole saliva samples was per-
formed under resting conditions in a quiet room during the after-
noon between 14 : 00 and 15 : 00 h, at least 1 h after eating. The
saliva samples were mixed with nine parts of physiological saline
and homogenized using an IKA homogenizer (IKA-Werke, Ultra-
Turrax T8) for 1 min in an ice bath. Trypsin- like activities were
measured using 100 μl of the whole homogenate diluted to 10- fold
with 0.05 M Tris-HCl buffer (pH 8.6)/BSA (100 μg/ml). Thus, the
whole homogenatewas finally diluted to 1500-fold in an assaymix-
ture of 1.5 ml.
HAT concentrations were measured by ELISA as described
above using 50 μl of the whole homogenate finally diluted to 100-
fold with PBS/2% Triton X-100/0.6% SDS.
Measurement of total protein
Unless otherwise stated, total protein was measured by the
method of Lowry et al. (17) using BSA as the standard. For purifica-
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tion of trypsin- like enzyme, total protein was measured using a
Micro BCA assay kit (Pierce, Rockford, IL).
Culture of oral cells
Human gingival fibroblasts (HGF) and gingival epithelial cells
(HGE) were cultured from human gingival tissues obtained during
surgery for cancer and tooth extraction. Before the surgery, writ-
ten informed consent was obtained from the patients after a full
explanation of the procedures involved. The experimental proce-
dure was approved by the Ethics Committee of the Kawashima
Hospital at Tokushima City (Approval No 0011).
In a previous study, we cultured human bronchial fibroblasts
(HBF) in DMEM supplemented with 10% FBS (11). HGF were
cultured in almost the same manner as previously reported using
gingival tissues. Experiments were performed using cells between
passages 2 and 5.
HGE (human gingival epithelial cells) were cultured as previ-
ously reported (18), using keratinocyte- SFM/supplemented with
BPE and EGF. All experiments were performed with cell pas-
sages 1 (P1) or 2 (P2).
RT-PCR for HAT and GAPDH mRNA extracted from human oral
cells
Oral cells (both HGF and HGE) were seeded into 60-mm cell
culture dishes and incubated at 37 until 100% confluence. Total
cellular RNA was extracted from the cells using Isogen (Nippon
Gene, Tokyo, Japan), according to the manufacturer’s instructions.
RT-PCR procedures for HAT were performed as described previ-
ously (19). Sense and antisense primers for RT-PCR were synthe-
sized, and the sequences were as follows : sense primer, 5’ -
CATTG TCGTC GCAGG GGTAG-3’ ; antisense primer, 5’ -TCAGC
CTCAG TGCCT CCAAG-3’. The length of the expected PCR
product was 519 bp. GAPDH was used as an internal control. The
PCR products were electrophoresed on 1.5% agarose gels and
stained with ethidium bromide solution and visualized by UV
transillumination.
Immunofluorescence and western blotting
When fibroblasts differentiate into myofibroblasts, α -SMA fiber
expression is observed in the fibroblasts (20-22). Therefore, ex-
pression of SMA fiber was used as a marker for fibroblast - to-
myoblast differentiation in this study. Effect of HAT on α -SMA
fiber expression in HGF was examined by both indirect im-
munofluorescence and western blotting.
HGF were obtained from the gingival tissues of a total of 10
subjects, seeded on cover slips (18 mm × 18 mm) in 6-well plates
(Greiner), and cultured in DMEM supplemented with 10% FBS for
23 days in a 5% CO2 incubator until 5060% confluence. After
incubation for 24 h in serum-free DMEM supplemented with 0.01%
BSA, the cells were stimulated with HAT at 7.560 nM for 2448 h.
The cells were gently washed with PBS, fixed with 4% parafor-
maldehyde at room temperature for 20 min, and then treated with
0.1% Triton X-100 in PBS for 34 min at 4. After blocking the
fixed cells with PBS/1% BSA for 20 min at room temperature,
cells were incubated with 1 : 200 dilution of monoclonal anti -α -
smooth actin antibody (Sigma) at 4 overnight, followed by in-
cubation with Alexa 488-anti -mouse IgG antibody for 12 h at
room temperature. Fluorescent images of cell sections excited at
488 and 560 nm were captured using a confocal laser scanning
microscope (Leica TCS NT, Heidelberg, Germany) equipped with
an argonkrypton laser source. As a control, the immunostaining
procedure was performed with normal mouse IgG instead of anti-
actin antibody.
Western blotting
HGF (15 × 104 cells) were cultured in a 6-well culture plate
(Greiner) in DMEM supplemented with 10% FBS in a 5% CO2
incubator for 24 h at 37. The culture medium was changed to
serum-free DMEM, and the cells were cultured for an additional
24 h. Fibroblasts were stimulated with HAT (7.560 nM) in the
same medium for 1272 h. The cells were washed with PBS,
scraped off the wells in 0.4 ml cell lysis buffer (Cell Signaling,
Denvers, MA) containing protease inhibitor cocktail (Roche Diag-
nostics, Indianapolis, IN), sonicated, and centrifuged at 14,000 ×g
for 10 min at 4.
The protein concentration of the resultant supernatant was
measured using the Micro BCA protein assay reagent kit.
The supernatants were diluted to 24- fold with SDS sample
buffer and boiled for 5 min. The same amount of cell lysate protein
(0.2 μg) was separated by SDS-PAGE on 10% gel (Greiner) under
reducing condition. Pre-stained broad-range protein standards
(Apro Science, Naruto city, Japan) were used to estimate the mo-
lecular mass. The proteins were transferred onto a polyvinylidene
difluoride membrane (Bio-craft Co., Tokyo, Japan). The amountof
α -SMA was estimated by western blotting using a monoclonal
anti -α -smooth muscle actin antibody as the primary antibody and a
peroxidase-conjugated monoclonal anti -mouse IgG antibody (GE
Healthcare) as the secondary antibody. GAPDH, which was used
as the loading protein control, was also detected as described
above using a monoclonal anti -GAPDH antibody (Sigma) as the
primary antibody.
Positive reactivity was detected using the ECL Western Blotting
detection kit (GE Healthcare). Signals on a film (GE Healthcare)
were detected by an X-ray film automatic processor using a TC-DF
202 processing system developer replenisher fixer (Konica Minolta
Me).
Effect of HAT on HGF proliferation
HGF were seeded at 4000 cells/well in a 96-well plate containing
100 μl of DMEM supplemented with 10% FBS until 7080% conflu-
ence. The cells were then cultured in serum-free DMEM supple-
mented with 0.01% BSA for 24 h, stimulated with HAT for 48 h in
the same medium, harvested from the plate by trypsinization,
and counted using a hemocytometer, as described previously by
Matsushima et al. (11).
Statistical analysis
Data are represented as meanSD. Significant differences be-
tween samples were tested by the nonparametric Wilcoxon
MannWhitney test. The significance of correlation between
trypsin- like activity and HAT concentration in the saliva samples
was tested using Pearson’s productmoment correlation coeffi-
cient. p0.05 was considered as statistically significant.
RESULTS
I Biochemical properties of trypsin-like protease purified from
saliva
The distribution of trypsin- like activity in the purified trypsin-
like protease from pooled saliva was very similar to that of mucoid
sputum (1) in each purification step, including hydrophobic gel
using Butyl -Toyopearl C column chromatography, anion-exchange
column chromatography using SP-Toyopearl 650M, and affinity
chromatography using Benzamidine-Sepharose 6B. Trypsin- like
protease was absorbed on the Butyl -Toyopearl C column equili-
brated with 40% ammonium sulfate (pH 7.5) and eluted with 5%
ammonium sulfate (pH 7.5), absorbed on SP-Toyopearl 650M
column equilibrated with 0.05 M sodium acetate (pH 4.0) and
eluted with a linear 00.20 M NaCl gradient, and absorbed on a
Benzamidine-Sepharose 6B column equilibrated with 0.05 M Tris-
HCl buffer/0.5 M NaCl (pH 9.2) and eluted with 0.05 M sodium
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acetate/0.5 M NaCl (pH 4.0).
Finally, approximately 2 μg of the purified enzyme (8% yield) was
obtained after purification, with activity about 330,000- fold that of
the starting material.
The substrate specificity of this material for synthetic model sub-
strates was examined as previously reported (1). For this, various
kinds of MCA substrates developed for assaying several proteases
were used, with rHAT as the control. The activity profiles of rHAT
on these substrates were almost similar to those of native HAT
purified from mucoid sputum (1). As shown in Table 1, the activity
profiles of the trypsin- like protease purified from saliva on these
substrates were almost similar to those of rHAT. Of the MCA sub-
strates tested, Boc-Phe-Ser-Arg-MCA (trypsin substrate) was
most preferentially hydrolyzed by both the purified enzyme and
rHAT.
Effects of protease inhibitors on the purified protease were also
examined as previously reported for native HAT (1) (Table 2). In-
hibitors, other than EDTA, were added at a concentration of 10 μM.
The activity of purified protease was completely inhibited by 10 μM
diisopropyl fluorophosphate (DFP) and was almost completely in-
hibited by trypsin inhibitors such as leupeptin, antipain, soybean
trypsin inhibitor, aprotinin, and urinary trypsin inhibitor ; how-
ever, the activity was not inhibited by amastatin, phosphorami-
don (a metalloprotease inhibitor), or 1 mM EDTA. As shown in
Table 2, the effects of these protease inhibitors on the purified
protease were almost similar to those on rHAT.
When the purified protease was subjected to gel filtration on a
Sephadex G-100 column, the elution pattern of its trypsin- like
activity was very similar to that of rHAT, with peaks of both trypsin-
like activity of purified protease and rHAT (mature HAT) located in
fraction 38 (Fig 1).
Thus, the results showing that biochemical properties of the
purified protease were almost similar to those of rHAT indicate that
purified protease was primarily composed of mature HAT. There-
fore, mature HAT is assumed to be released into the saliva.
Measurement of trypsin-like activity and HAT concentration in
the saliva samples
Saliva contains insoluble substances that precipitate on cen-
trifugation. We assumed that a considerable portion of proteins,
Table 1 Activities of trypsin - like protese purified from saliva on
synthetic model substrates
Substrate
Relative activity (%)**
Purified protease rHAT
Boc-Phe -Ser -Arg -MCA* 100 100
Boc-Val -Pro -Arg -MCA 88 88
Boc-Gln -Ala -Arg -MCA 51 48
Boc-Gln -Arg-Arg-MCA 32 34
Boc-Leu-Thr -Arg -MCA 80 76
Boc- Ile -Glu -Gly -Arg -MCA 7 6
Glt -Gly -Arg -MCA 12 11
Boc-Gln -Gly -Arg -MCA 68 70
Pro -Phe -Arg-MCA 13 12
Boc-Val -Leu-Lys -MCA 4 3
Suc-Ala -Ala -Pro -Phe -MCA 0 0
Suc-Ala -Pro -Ala -MCA 0 0
*MCA : Methyl -Coumaryl -7 -Amide
** Activity as a percentage of that with Boc-Phe-Ser -Arg-MCA
Table 2 Effects of protease inhibitors on the trypsin - like protease
purified fromsaliva
Addition Finalconcentration
Relative activity (%)
Purified protease rHAT
None 100 100
DFP 10μM 0 0
Leupeptin 10μM 2.8 2.5
Antipain 10μM 3.3 1.9
Soybean trypsin inhibitor 10μM 9.7 5.2
Aprotinin 10μM 0.5 0.2
UTI 10μM 0.2 0.2
Benzamidine 10μM 0.9 0
Amastatin 10μM 100 100
α -1 -protease inhibitor 10μM 46.7 53.5
Phosphoramidon 10μM 100 100
EDTA 1mM 100 100
DFP : diisopropyl fluorophosphate
UTI : urinary trypsin inhibitor
EDTA : ethylenediamine tetraactic acid
Fig 1 Gel filtration of a trypsin - like protease purified from the saliva
on a Sephadex G-100 column
A : Purified protease ; 28.8 mU of the trypsin - like protease purified from
the saliva was dissolved in 2 ml of 0.05 M Tris -HCl buffer (pH 7.5)/0.30M
NaCl and applied to a Sephadex G-100 column (2.2 × 65 cm) equilibrated
with the same buffer. Elution was performed at a flow rate of 15 ml/h at
4, and the elute was collected in fraction of 4 ml. Trypsin - like activity
was measured with Boc-Phe-Ser -Arg-MCA as the substrate. B : rHAT ;
0.2 μg of rHAT was subjected to gel filtration in the same way as de-
scribed above.
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including proteases, in the saliva were co-precipitated with insol-
uble substances by centrifugation. When saliva samples were mixed
with equal volumes of 0.1 M Tris-HCl buffer (pH 7.5)/0.30 M NaCl,
homogenized, and centrifuged at 8,000 rpm for 10 min, approxi-
mately 40% of trypsin- like protease activity in the original saliva was
precipitated with other macromolecules. Therefore, in the follow-
ing experiments to measure the trypsin- like activity and HAT con-
centration in the saliva samples, we analyzed whole saliva homo-
genate at the following dilutions : 1500- fold dilution with 0.05 M
Tris-HCl buffer (pH 8.6)/BSA (100 μg/ml) for assaying trypsin-
like activity and 100-fold dilution with PBS/2% Triton X-100/0.6%
SDS for assaying HAT concentration with ELISA for preventing the
loss of trypsin- like activity and HAT due to centrifugation.
The trypsin- like activities in the saliva samples from 60 middle-
aged healthy subjects were measured. In all the saliva samples di-
luted to 1500-fold, trypsin- like activity was detectable in a range of
5,35058,880 μU/ml, with the mean value and standard deviation
being 23.916.2 mU/ml. Moreover, immunoreactivity against
HAT in the present ELISA was also detectable in all the saliva sam-
ples diluted to 100- fold.
A saliva sample (5 ml) was diluted with five volumes (25 mL) of
buffer, concentrated by ammonium sulfate fractionation (2080%),
and subjected to gel filtration on a Sephadex G-100 column. The
elution pattern of immunoreactivity against ELISA for HAT was
very similar to that of trypsin- like activity. Both trypsin- like activity
and immunoreactivity to anti -HAT antibody in ELISA yielded only a
single peak, and peaks of both trypsin- like activity and immunoreac-
tivity were located in fraction 38, where the rHAT peak was located.
Fig 2 shows the result of gel filtration of the saliva sample. In gel
filtration, almost similar results were obtained in the seven saliva
samples tested.
Correlation between trypsin- like activity and HAT concentra-
tion was tested in healthy subjects (N = 60). As shown in Fig 3,
trypsin- like activity was significantly correlated with HAT concen-
tration, as measured by present ELISA (r = +0.922 ; p0.01).
These results support the idea that saliva samples from healthy
subjects contain mature HAT, indicating that the Boc-Phe-Ser-
Arg-MCA-hydrolyzing activity of the saliva was primarily due to
mature HAT.
Comparison of trypsin-like activity level and HAT concentra-
tion in the saliva with those in the mucoid sputum
In a previous experiment (13), the mean value of the total protein
concentration, trypsin- like activity, and HAT concentration were
not significantly different between the saliva samples collected by
the suction and spitting methods (data not shown). Therefore, in
the following experiment, saliva samples collected by the suction
method were analyzed.
In the saliva sample from healthy subjects (N = 60), the mean
values of total protein concentration (μg/ml), trypsin- like activity
(mU/ml), and HAT concentration (ng/ml) were 33401638, 23.9
16.7, and 153112, respectively.
As shown in Table 3, mean value of the total protein concentra-
tion, trypsin- like activity, and HAT concentration in the mucoid
sputum (N = 60) were 1.9-, 2.62-, and 2.69- fold higher, respec-
tively, in the mucoid sputum than those in the saliva samples ;
the difference in each parameter between the saliva samples and
mucoid sputum was significant. As shown in Fig 4, the ratio of
HAT concentration to total protein concentration (HAT : TP
ratio ; ng/mg)wasalmost similar in the saliva andmucoid sputum
samples.
Expression of HAT mRNA in HGE and HGF
In this study, as a method to clarify the origin of HAT in saliva,
RT-PCR for HAT mRNA was performed using HGF and HGE as
target cells.
PCR products were electrophoresed on 1.5% agarose gels. As
shown in Fig 5, the expression of HAT mRNA was clearly de-
tected in HGE but not in HGF, whereas expression of GAPDH
mRNA was almost the same in these cells.
Analyzing the effect of HAT on α-SMA fiber expression in HGF
by indirect immunofluorescenceandwesternblotting
Expression of intracellular SMA fiber was used as the marker for
observing fibroblast - to-myoblast differentiation in this study. Ten
HGF samples were obtained from various gingival tissues. When
the HGF was not stimulated with HAT, the intracellular immunofluo-
rescence intensity of α -SMA varied considerably among the sam-
ples. Of the total unstimulated HGF, α -SMA fiber was either not
detectable or very weak in six samples (group A), as shown in
Fig 6A, whereas in another four samples (group B), it was clearly
and prominently visible even in unstimulated condition (Fig 7A).
This result was thought to be a consequence of the fact that HGF
were obtained from the gingival tissues with various kinds of in-
flammation in the present study.
In group A HGF, HAT clearly induced α -SMA fiber expression
and also increased the cell size (Fig 6C). The cell sizes of HAT-
treated HGF were 24-fold larger than those of control cells
(Fig 6A). TGF-β1, a positive control that differentiates fibroblasts
into myofibroblasts, also induced α -SMA expression in HGF(Fig 6
B). Furthermore, even in HGF, in which α -SMA fiber formation
Fig 2 Gel filtration of saliva from a healthy subject on a Sephadex G-
100 column
Five milliliter of saliva was mixed with equal volume of 0.100 M Tris -HCl
buffer (pH 7.5)/0.30 M NaCl and centrifuged at 8,000 rpm at 4. The
resultant supernatant was subjected to ammonium sulfate fractionation,
and 2080% ammonium sulfate fraction was dissolved in 4 ml of 0.05 M
Tris -HCl buffer/0.30 M NaCl. Two milliliter of this solution was sub-
jected to gel filtration, and trypsin - like activity was measured as de-
scribed in Fig 1. HAT concentration was measured by ELISA as de-
scribed in the Materials and Methods.
A : Absorption at 280 nm. B : Trypsin- like activity (closed), HAT con-
centration (opened).
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had already occurred, HAT significantly enhanced α -SMA fiber
expression compared to that in the control (Fig 7A and B ).
Western blotting
Western blot analysis was performed in HGF obtained from
group A donors. When HGF were stimulated with HAT, HAT
clearly induced α -SMA expression in the range of 7.560 nM in a
dose-dependent fashion after 48 h. Extent of α -SMA expression
varied among the fibroblasts obtained from different donor pa-
tients and was at the maximum level at a HAT concentration of ap-
proximately 3060 nM. Fig 8 is a typical example of the effect of
HAT concentration on α -SMA expression. HAT-induced α -SMA
expression was at the maximum level at 4872 h (data not shown).
Increase in SMA expression with 30 nM HAT was similar to that
with 100 pg/ml of TGF-β1 (Fig 9).
Effect of HAT on HGF proliferation
Effect of HAT on HGF proliferation was examined in other HGF
samples different from those subjected to western blot analysis. As
shown in Table 4, direct counting of cell number using a hemocy-
tometer showed that HAT at 15, 30, and 60 nM slightly but signifi-
cantly increased the cell number by 1540% above the control
value. Although this stimulatory effect of HAT on HGF proliferation
was slight, and varied among samples, it was reproducible in all the
four separate samples tested.
DISCUSSION
Following the discovery of mature HAT for the first time in
human mucoid sputum from patients with chronic airway diseases
(1), this study was primarily undertaken to clarify whether mature
HAT is released in human saliva. When purification of trypsin- like
protease from pooled saliva was performed using a method similar
to that adopted for purification of HAT from mucoid sputum,
distribution of trypsin- like activity of saliva in each purification step
was very similar to that of HAT in the mucoid sputum (1). In this
study, the yield of trypsin- like activity in the purified product was
approximately 10%, with 330,000- fold increase in activity compared
to that starting material. This value was similar to the yield after
purification of HAT from the mucoid sputum. Moreover, bio-
chemical properties, such as substrate specificity for various syn-
thetic model substrates, behavior to protease inhibitors, and mo-
lecular weight estimated by gel filtration using Sephadex G-100
column, of this purified protease were almost similar to those of
rHAT. These results strongly indicated that human saliva contains
mature HAT.
Preliminary experiments showed that when saliva samples were
diluted 2-fold and centrifuged, approximately 40% of trypsin- like
protease activity was precipitated along with other macromole-
cules. Therefore, in the following experiments, to measure the total
trypsin- like activity and HAT concentration in saliva samples, we
used whole saliva homogenate as the test material. The saliva ho-
mogenates were finally diluted to 1500-fold for assaying trypsin-
like activity and to 100-fold in PBS/2% Triton X-100/0.6% SDS for
assaying HAT by ELISA. Therefore, most of the HAT contained in
the whole homogenates was probably soluble in the present assay
mixture used for determining trypsin- like activity and HAT con-
centration .
Trypsin- like activity was detected in all the 1500-fold diluted
saliva homogenates from all healthy subjects, and immunoreac-
tivity to anti -HAT antibody in ELISA was also detected in all the
100-fold diluted saliva homogenates. As shown in Fig 3, trypsin-
like activity was significantly and positively correlated with HAT
immunoreactivity in ELISA (r = +0.922, p0.01) for whole saliva
homogenate. Moreover, in gel filtration of the concentrated origi-
nal saliva on a Sephadex G-100 column, peaks of both trypsin-
like activity and immunoreactivity to anti -HAT were observed in
the fraction where rHAT was eluted. These results indicated that
Fig 3 Relationship between trypsin - like activity and HAT concentra-
tion in the saliva samples from healthy subjects
Each saliva sample was mixed with nine parts of physiological saline and
homogenized using a IKA homogenizer (IKA-Werke, Ultra -Turrax T8)
for 1 min in ice -bath.
For assaying trypsin - like activity, the saliva whole homogenates were
finally diluted to 100- fold with 0.05 M Tris -HCl buffer (pH 8.6)/BSA
(100 μg/ml), and the trypsin - like activities were measured using
100 μl of the diluted whole saliva homogenate. For assaying HAT con-
centration, the saliva whole homogenates were finally diluted to 100- fold
with PBS/2% Triton X-100/0.6% SDS. HAT concentration was meas-
ured by ELISA using 50 μl of the whole homogenate.
Table 3 The trypsin - like activity and HAT concentration in saliva samples from heathy subjects and
mucoid sputum samples from patients with chronic airway diseases
Sample n Total proteinμg/ml p
Trypsin- likeactivity
mU/ml p
HAT
ng/ml p
Saliva 61 3,3401,638 23.916.7 153112
p0.001 p0.001 p0.001
Sputum 61 6,5676,221



 62.868.7



 413511




Values are meansSD.
P : p value tested for diffrence between saliva and sputum samples by the Wilcoxon-Mann-
Whiteney test
The Journal of Medical Investigation Vol. 65 August 2018 263
Fig 4 The ratio of HAT concentration to the total protein concentra-
tion in the saliva and mucoid sputum samples
Horizontal lines indicate mean values. * ns : not significant
Fig 5 Analysis of the expression of HAT mRNA in primary human
gingival epithelial cells (HGE) and humangingival fibroblast (HGF) by
RT-PCR
Oral cells (both HGF and HGE) were cultured as described in the
Materials and Methods. These cells were seeded into 60-mm cell culture
dishes and proliferated in each growth medium until confluence.
Total cellular RNA was extracted from the cells using Isogen (Nippon
Gene, Tokyo, Japan) according to the manufacturer’s instructions. RT-
PCR procedures for HAT were performed as described previously (19).
The length of the expected PCR product was 519 bp. Glyceraldehyde-3 -
phosphate dehydrogenase (GAPDH) mRNA was used as the control for
HAT mRNA. The PCR products were electrophoresed on 1.5% agarose
gels and stained with ethidium bromide.
A : HAT mRNA ; line 1, Molecular markers ; line 2, HGF ; line 3, HGE.
B : GAPDH mRNA.
Fig 6 Analysis of the effect of HAT on the expression of α - smooth
muscle actin in HGF by indirect immunofluorescence staining (1)
Group A HGFs were seeded onto 18 × 18 mm cover glasses in 6 -well
plates in DMEM supplemented with 10% FBS, and cultured to 60% conflu-
ence. After they were cultured in serum-free DMEM for 24 h, the cells
were either stimulated with HAT (30 nM) or TGF-β1 (100 pg/ml) for
48 h or were not stimulated. Indirect immunofluorescence staining of α -
smooth muscle actin was performed as described in the Materials and
Methods.
A : control cells. B : TGF-β1 (100 pg/ml) - treated cells. C : HAT (30 nM)-
treated cells.
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the trypsin- like activity of saliva is primarily due to mature HAT,
supporting the idea that saliva contains mature HAT.
It was considered that when saliva is collected by the suction
method, precursor HAT of oral cells may be activated by negative
pressure due to suction and processed into mature HAT. How-
ever, in the preliminary experiments, mature HAT was present in
the saliva collected by the spitting method, wherein negative pres-
sure was not inducted. Both trypsin- like activity and immunoreac-
tive HAT concentration were almost similar in the saliva collected
by the suction and spitting methods in healthy subjects. There-
fore, mature HAT is thought to be released into the saliva, regard-
less of the method of saliva collection.
As shown in Fig 4, the HAT : TP ratio (ng/mg) was almost
similar in the saliva and mucoid samples, suggesting that mature
HAT is actively released in the saliva in the healthy state as it is
released into the bronchial secretion in chronic airway disease.
As described previously (1), mature HAT was first isolated from
the mucoid sputum. Because the mucoid sputum was expectorated
by all patients, it was relatively contaminated with saliva. There-
fore, it was considered that the mucoid sputum may contain both
airway- and saliva-derived HAT. The ratio of airway-derived HAT
to saliva-derived HAT in the expectorated mucoid sputum sam-
ples is considered to be different among the samples. Chronic air-
way diseases, such as chronic bronchitis, are accompanied with
airway hypersecretion (23). In patients with hypersecretory chronic
airway diseases, the proportion of airway-derived HAT to total
HAT in the mucoid sputum samples is assumed to increase with the
degree of airway hypersecretion.
Fig 7 Analysis of the effect of HAT on α - smooth muscle actin expres-
sion in HGF by indirect immunofluorescence staining (2) Group B :
Experimental procedures were performed as described in Fig 6.
A : control cells. B : HAT (30 nM)-treated cells.
Fig 8 Analysis of the effect of HAT on α - smooth muscle actin expres-
sion in HGF by western blotting (1)
Dose response : HGFs were seeded into in 6 -well plates (Greiner) in
DMEM supplemented with 10% FBS and cultured to 60% confluence.
After they were cultured in serum-free DMEM for 24 h, the cells were
cultured without stimulus or with HAT (7.5~60 nM) for 48 h.
HAT concentration : 1, control ; 2, 7.5 nM ; 3,15 nM ; 4,30 nM ; 5,60 nM.
Western blotting was performed as described in the Materials and Meth-
ods.
Fig 9 Analysis of the effects of HAT and TGF-β1 on α - smooth muscle
actin expression in HGF by western blotting (2)
Experimental procedures were performed as described in Fig8. Western
blotting was performed as described in the Materials and Methods.
1, control ; 2, HAT (30 nM) ; 3, TGF-β1 (50 pg/ml) ; 4, TGF-β1 (100 pg/
ml).
Table 4. Effect of HAT on proliferation of HGF
Protease Concentration(nM) Number of Cell/well(×104)
Control 1.180.11
HAT 15 1.290.05*
HAT 30 1.390.07*
HAT 60 1.410.12*
Data are presented as meansSD from 8 well.*P0.05 compared with
control.
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Previous investigations have shown that HAT is expressed in
various tissues, particularly in the epithelial cells of upper respira-
tory and gastrointestinal tracts, including oral tissues (5-9). Oral
tissues are closely localized in both the upper respiratory and gas-
trointestinal tracts. These results indicate that HAT is expressed in
the epithelial cells in healthy state in these organs. No investigators
have analyzed HAT mRNA expression in oral cells cultured in vitro.
The present study showed that HAT mRNA is prominently ex-
pressed in gingival epithelial cells, whereas it was not detected in
gingival fibroblasts. These results further prove that HAT is ex-
pressed in epithelial cells in the oral cavity in healthy state. HAT
mRNA expression has been observed in primary bronchial epithe-
lial cells by RT-PCR in our lavaratory (19).
We consider that HAT plays certain roles at least at two different
locations in the airways and oral cavity ; it functions on the epi-
thelial cells where it is biosynthesized or in the neighboring cells
and at locations distant from the epithelial cells after it is released.
Mature HAT detected in the saliva and mucoid sputum is as-
sumed to correspond to that released.
Previous investigators have reported that serine proteases,
such as thrombin and mast cell tryptase, are involved in fibroblast
proliferation (24-25) and in fibroblast - to-myofibroblast differen-
tiation (20-22). In the present study, we examined whether HAT
enhances the differentiation of HGF into myofibroblasts or not by
assessing the expression of α -SMA fiber, a marker of myofibro-
blast (20-22, 26-27), by immunofluorescence and western blotting.
Our results suggested that HAT enhances SMA fiber expression,
irrespective of the existence of intracellular SMA fiber in HGF, be-
cause the SMA expression-enhancing activity of HAT was ob-
served in HGF both in which intracellular SMA expression was not
detected and in those in which SMA expression was detected.
The SMA expression-enhancing activity of HAT in HGF was also
confirmed by western blotting. In this method, the extent of α -
SMA expression induced by 100 mU/ml (30 nM) HAT was similar
to that induced by 100 pg/ml TGF-β1.
There were some differences between HAT and TGF-β1 with
respect to the dose response of SMA expression-enhancing activity.
HAT activity reached a plateau at a concentration of 30

60 nM
(100

200 mU/ml), whereas TGF-β1 activity increased with con-
centration of 100

1000 pg/ml. This could be explained by the fact
that the mechanism of the SMA expression-enhancing activity
of HAT differs from that of TGF-β1. TGF-β1 induces fibroblast - to-
myofibroblast differentiation via its cell surface receptor (28).
However, HAT may enhance fibroblast - to-myofibroblast differen-
tiation via cell surface protein receptors different from the TGF-β1
receptor. Because HAT is a serine protease, it is assumed to
hydrolyze several cell surface proteins that are related to various
cellular functions.
Hitherto, it has been demonstrated that HAT attacked urinary
type-plasminogen activator receptor (uPAR) in human bronchial
epithelial cells (HBEC) (6), and protease-activated receptor-2 in
HBEC, bronchial fibroblasts, and keratinocytes (11, 29-30). How-
ever, in fibroblast - to-myofibroblast differentiation, the target pro-
tein on the cell surface of HGF that HAT initially attacks is yet un-
known. This problem is now under investigation in our laboratory.
We have previously reported in HBF that the extent of HBF
growth-stimulating activity of HAT was slight, but this activity of
HAT was reproducible by direct counting of cell number and the 3H-
thymidine uptake method (11). The present study showed that the
fibroblast proliferation-stimulating activity of HAT was also low in
HGF, similar to that in HBF. Furthermore, HAT enhanced the
stimulation of fibroblast - to-myofibroblast differentiation and en-
larged the cell size.. These results strongly suggested that HAT
had higher ability to stimulate fibroblast - to-myofibroblast differ-
entiation than that to stimulate fibroblast proliferation in HGF.
Myofibroblast differentiation from fibroblasts contributes to the
healing process, tissue remodeling, and fibrotic disorders (20-22).
Fibroblast - to-myofibroblast differentiation is regulated by various
cytokines and proteases (20-21, 26-27). This study showed that
HAT enhanced fibroblast - to-myofibroblast differentiation at a con-
centration of 10

60 nM (10 200 mU/ml) in vitro. Therefore, mature
HAT may exist at an adequate concentration to induce myofibro-
blast transformation in the oral tissues.
These results indicate that HAT may be related to some physi-
ological functions and pathological states, concerning myofibro-
blasts, in the oral cavity.
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